Filter Results
:
(412)
Show Results For
-
All HBS Web
(641)
- People (4)
- News (100)
- Research (412)
- Events (3)
- Multimedia (4)
- Faculty Publications (252)
Show Results For
-
All HBS Web
(641)
- People (4)
- News (100)
- Research (412)
- Events (3)
- Multimedia (4)
- Faculty Publications (252)
Sort by
- 23 Jul 2001
- Research & Ideas
How Relationships are Building Biotech
on biotech companies in terms of securing resources. And if the top executives had a career background at a pharmaceutical and/or healthcare company—the companies considered...
View Details
Keywords:
by Martha Lagace & Mallory Stark
- 26 Jul 2010
- Research & Ideas
Yes, You Can Raise Prices in a Downturn
As economic turmoil continues, many companies are reconsidering their strategies with an eye toward going lean and slashing prices. And that might work for a few companies—but very few. Instead, companies...
View Details
- 03 Nov 2015
- First Look
November 3, 2015
quantify the impact of scientific grant funding at the National Institutes of Health (NIH) on patenting by pharmaceutical and biotechnology firms. Our paper makes two contributions. First, we use newly constructed bibliometric data to...
View Details
Keywords:
Sean Silverthorne
- 12 Jan 2016
- First Look
January 12, 2016
November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing drug surveillance is the process of monitoring the adverse...
View Details
Keywords:
Carmen Nobel
- 05 Aug 2008
- First Look
First Look: August 5, 2008
/b01/en/common/item_detail.jhtml?id=808167 The Coartem Challenge (A) Harvard Business School Case 706-037 In November 2005, Novartis, a major global pharmaceutical firm, is reviewing its Coartem program, an ambitious attempt to deliver...
View Details
Keywords:
Martha Lagace
- 03 Feb 2015
- First Look
First Look: February 3
architecture, including business- and technology-related aspects. We apply our methodology to data gathered in a large pharmaceutical firm. We show that this methodology helps to identify layers in the firm's architecture associated with...
View Details
Keywords:
Sean Silverthorne
- 30 Apr 2001
- Research & Ideas
Entering the Age of Alliances
competencies of each partner and create two-way value is evidenced by, among others, the collaboration between The College Fund (UNCF) and Merck. UNCF, the largest and oldest minority educational assistance organization in the United States, and Merck, a leading global...
View Details
Keywords:
by James Austin
- 12 Jan 2010
- First Look
First Look: Jan. 12
and illustrates, via a detailed description of the successful strategic alliance between Solvay Pharmaceuticals Inc. and Quintiles company how the creation of a strategy map and Balanced Scorecard helps...
View Details
Keywords:
Martha Lagace
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the...
View Details
Keywords:
Martha Lagace
- 24 Apr 2018
- First Look
First Look at New Research and Ideas, April 24, 2018
Bird, Yanhua Z., Jodi L. Short, and Michael W. Toffel Abstract—Exploitive working conditions have spurred companies to pressure their suppliers to adopt labor codes of conduct and to conform their labor practices to the standards set...
View Details
Keywords:
Sean Silverthorne
- 29 Jan 2013
- First Look
First Look: Jan. 29
facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals...
View Details
Keywords:
Sean Silverthorne
- 18 Dec 2012
- First Look
First Look: December 18
pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's global head of R&D, championed the acquisition of Sirtris to gain access...
View Details
Keywords:
Carmen Nobel
- 28 May 2008
- First Look
First Look: May 28, 2008
goals? Purchase the case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=308030 Can PACIV (Puerto Rico) Serve European Customers? Harvard Business School Case 808-099 Jorge Rodriguez-Gonzalez, PACIV's (Puerto Rico) founding CEO, is considering expanding...
View Details
Keywords:
Martha Lagace
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
accessible corporate archives in most countries in Africa, Asia, and Latin America. It also permits a level of nuance that is hard to obtain even if written archives are accessible. Oral histories provide insights into why events did not occur as well as why View Details
Keywords:
Dina Gerdeman
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
series on AIDS in Africa and how pharmaceutical companies should think about the issues and how they might respond. Sandra Sucher has done a really wonderful case on Gleevec, which is a drug for treating...
View Details
- 03 Sep 2013
- First Look
First Look: September 3
results. Purchase this case: http://hbr.org/search/713537-PDF-ENG Harvard Business School Case 814-014 Sample6: Innovating to Make Food Safer Tim Curran, CEO of Sample6, a start-up biotechnology company developing a novel food safety...
View Details
Keywords:
Sean Silverthorne
- 24 Feb 2009
- First Look
First Look: February 24, 2009
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=909036 Esser & Ackermann at Mannesmann Harvard Business School Case 209-095 No abstract is available at this time. Purchase this case:...
View Details
Keywords:
Martha Lagace
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
of one of the top pharmaceutical companies in the world. Vasella, an avowed advocate of diversification, had expanded the scope of the company and structured it into 16...
View Details
Keywords:
Carmen Nobel
- 02 Apr 2013
- First Look
First Look: April 2
care needs to go "beyond the pill" and systematically integrate combinations of treatments. We discuss the implications of this approach for organizational and business models in the pharmaceutical industry. 2006 World Politics...
View Details
Keywords:
Sean Silverthorne
- 09 Jan 2007
- First Look
First Look: January 9, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707413 Teva Pharmaceutical Industries, Ltd. Harvard Business School Case 707-441 Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707441 ...
View Details
Keywords:
Martha Lagace